找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Glaucoma Surgery; Treatment and Techni Luigi Caretti,Lucio Buratto Book 2018 Springer International Publishing AG 2018 Micro-Invasive Glauc

[復(fù)制鏈接]
樓主: Limbic-System
31#
發(fā)表于 2025-3-26 21:05:30 | 只看該作者
Hypernovae and Gamma-Ray Bursts,Glaucoma Drainage Devices (GDDs) or shunts were proposed by Molteno and coll in 1968 for the treatment of refractory glaucomas, meaning those cases at a high risk of failure following filter surgery or in cases in which surgery was already not successful.
32#
發(fā)表于 2025-3-27 01:40:58 | 只看該作者
https://doi.org/10.1007/b117116In recent years, we have seen large development of laser technology in ophthalmology.
33#
發(fā)表于 2025-3-27 08:00:01 | 只看該作者
Interactive Data Selection in Power View,Following detailed and correct diagnosis, the best procedure for the treatment of glaucoma is chosen on the basis of:
34#
發(fā)表于 2025-3-27 10:30:22 | 只看該作者
Anatomy,In glaucoma surgery, comprehensive knowledge and understanding of the sclero-corneal limbus and the anatomy of the irido-corneal angle (Figs. 1.1, 1.2, 1.3, 1.4, 1.5, and 1.6) are absolutely essential.
35#
發(fā)表于 2025-3-27 17:41:05 | 只看該作者
Anesthesia,The anesthesia used in a surgical procedure for glaucoma depends primarily on the surgeon’s personal preferences. However, the complexity of the surgical procedure, the presence of other systemic clinical conditions and patient collaboration also play important roles.
36#
發(fā)表于 2025-3-27 19:22:15 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:02 | 只看該作者
Laser Antiglaucomatous Treatments,In recent years, we have seen large development of laser technology in ophthalmology.
38#
發(fā)表于 2025-3-28 02:13:01 | 只看該作者
The Choice of Glaucoma Treatment,Following detailed and correct diagnosis, the best procedure for the treatment of glaucoma is chosen on the basis of:
39#
發(fā)表于 2025-3-28 09:48:49 | 只看該作者
High energy neutrino and gamma-ray astronomy compliance to treatment. Several surgical options are available; they have different degrees of efficacy and also different complication rates. The decision regarding the treatment pathway is taken on a case by case basis, and this makes a standard treatment protocol difficult to define.
40#
發(fā)表于 2025-3-28 13:53:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 08:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
西青区| 鸡东县| 乾安县| 柘荣县| 高平市| 浦东新区| 十堰市| 长顺县| 平南县| 宿州市| 宁城县| 桐梓县| 府谷县| 高安市| 沙田区| 恭城| 利津县| 霸州市| 毕节市| 万荣县| 紫金县| 治多县| 延吉市| 福鼎市| 马龙县| 大安市| 静海县| 澄城县| 依安县| 南部县| 新竹市| 和林格尔县| 禄劝| 北宁市| 扶沟县| 荥经县| 蓬溪县| 洛扎县| 石嘴山市| 同江市| 衢州市|